Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, November 26, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction
Life Sciences Times
-
November 26, 2025
Pharma
AstraZeneca’s IMFINZI Gets First U.S. Approval for Perioperative Use in Early Gastric and GEJ Cancers
Life Sciences Times
-
November 26, 2025
Pharma
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
Life Sciences Times
-
November 25, 2025
Pharma
Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program
Life Sciences Times
-
November 25, 2025
Pharma
PharmaEssentia Highlights Publication of Phase 3 SURPASS-ET Trial Results in The Lancet Haematology
Life Sciences Times
-
November 24, 2025
Pharma
FDA Approves Promega OncoMate MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA and LENVIMA in Advanced Endometrial Carcinoma
Life Sciences Times
-
November 11, 2025
0
Pharma
City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant
Life Sciences Times
-
November 10, 2025
0
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
0
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
0
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
0
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
0
Pharma
Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease
Life Sciences Times
-
October 27, 2025
0
Pharma
Zymeworks Reports Promising Early Data from Phase 1 Study of ZW191 Targeting Folate Receptor-Alpha in Advanced Solid Tumors
Life Sciences Times
-
October 24, 2025
0
Pharma
Verastem Oncology Reports Promising Early Results from Ongoing Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor
Life Sciences Times
-
October 24, 2025
0
Pharma
CDR-Life Reports Early Clinical Data Showing Pharmacodynamic Activity of CDR404 in MAGE-A4 Positive Solid Tumors
Life Sciences Times
-
October 24, 2025
0
Pharma
FDA Grants Priority Review for KEYTRUDA and KEYTRUDA QLEX, Each in Combination with Padcev, for Certain Patients with Muscle-Invasive Bladder Cancer
Life Sciences Times
-
October 23, 2025
0
Pharma
Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma
Life Sciences Times
-
October 23, 2025
0
1
2
3
...
83
Page 1 of 83
Most Read
GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool
November 26, 2025
Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction
November 26, 2025
Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs
November 26, 2025
EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer
November 26, 2025